Effects of PGRMC1 knockdown and PGRMC1 overexpression on cell viability, apoptosis, and level of apoptotic factors in resistant (MES-SA/DxR-2 lM and MES-SA/DxR-8 lM) and sensitive (MES-SA) uterine sarcoma cells. a Effect of PGRMC1 knockdown on the viability of MES-SA, MES-SA/DxR-2 lM, and MES-SA/DxR-8 lM cells treated with doxorubicin in a dosedependent manner. MTT-based viability assays were performed in which 7000 MES-SA, MES-SA/DxR-2 lM, and MES-SA/DxR-8 lM cells were seeded into 96-well plates for overnight incubation, followed by pretreatment with 60 nM PGRMC1-specific small interfering RNA (siRNA) or the corresponding GC content of scrambled (mis-matched) siRNA. Within 24 h, the cells were treated with the indicated doxorubicin concentrations for 48 h, followed by incubation with MTT for 4 h. Dimethyl sulfoxide (DMSO) was then added and the plates shaken for 20 min followed by absorbance measurement at 540 nm. Values were normalized against the untreated samples and are the average of four independent measurements ± SD. *P \ 0.05; **P \ 0.01; ***P \ 0.001 vs. Erratum to: PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma 2413
